Satellogic Form 4/A: Director receives 49k RSUs, no share sales
Rhea-AI Filing Summary
Satellogic Inc. (SATL) – Form 4/A insider filing
Director Ted Wang reported the grant of 49,435 Restricted Stock Units (RSUs) on 23 June 2025. The RSUs were awarded at no cost as part of director compensation and will convert into Class A common shares after they vest on 31 May 2026, subject to Mr. Wang’s continued service. The recipient has elected to defer actual share settlement until 31 May 2036. Following this award, Mr. Wang beneficially owns 49,435 derivative securities linked to Class A stock. No open-market purchases or sales were disclosed, and no cash consideration was exchanged.
The filing does not alter share count or cash flows for Satellogic, but it modestly strengthens board-level equity alignment.
Positive
- Enhanced director-shareholder alignment: 49,435 RSUs link compensation directly to future share performance.
- Deferred settlement until 2036 minimizes near-term dilution pressure.
Negative
- None.
Insights
TL;DR: Routine RSU award; aligns director incentives, limited market impact.
The filing documents a standard equity grant rather than a purchase or sale. Because the RSUs were issued at zero cost and are subject to a one-year vesting cliff, the disclosure mostly concerns future dilution—<0.1% of the 78 million shares outstanding—and therefore has negligible valuation effect. Deferral to 2036 pushes any share issuance well into the future, mitigating near-term dilution. Investors may view the award positively as it increases director ownership, but the transaction is immaterial to fundamentals in the short run.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 49,435 | $0.00 | $0.00 |
Footnotes (1)
- F1. Mr. Wang was granted 66,384 RSUs on June 23, 2025, all of which will vest on May 31, 2026 subject to Mr. Wang's continued service through such date. Grantee elected to defer receipt of shares until May 31, 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.